Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating promising results in the management of type 2 diabetes. This synthetic peptide resembles the actions of naturally present GLP-1, a https://charliefhvj833980.bluxeblog.com/71314046/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes